FDA.reportPublic FDA data

55000 MG anacaulase-bcdb 0.088 MG/MG Topical Gel [Nexobrid]

RxCUI
2626758
RxNorm name
55000 MG anacaulase-bcdb 0.088 MG/MG Topical Gel [Nexobrid]
Display name
55000 MG anacaulase-bcdb 0.088 MG/MG Topical Gel [Nexobrid]
Full name
55000 MG anacaulase-bcdb 0.088 MG/MG Topical Gel [Nexobrid]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:49

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761192Nexobridanacaulase-bcdb351(a)Disc2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NEXOBRIDANACAULASE-BCDBVericel Corporation1a2f23ad-78ef-43fa-9864-6bd77aac9e572025-09-11Warnings, Adverse reactionsExact identifier
rxcui: 2626758

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
1a2f23ad-78ef-43fa-9864-6bd77aac9e5755000 MG anacaulase-bcdb 0.088 MG/MG Topical Gel [Nexobrid]SBD10These highlights do not include all the information needed to use NEXOBRID safely and effectively. See full prescribing information for NEXOBRID. NEXOBRID ® (anacaulase-bcdb), for topical gel Initial U.S. Approval: 202220250911
1a2f23ad-78ef-43fa-9864-6bd77aac9e5755000 MG Nexobrid 0.088 MG/MG Topical GelSY10These highlights do not include all the information needed to use NEXOBRID safely and effectively. See full prescribing information for NEXOBRID. NEXOBRID ® (anacaulase-bcdb), for topical gel Initial U.S. Approval: 202220250911
1a2f23ad-78ef-43fa-9864-6bd77aac9e57NexoBrid 8.8 % Topical Gel, 55 GMPSN10These highlights do not include all the information needed to use NEXOBRID safely and effectively. See full prescribing information for NEXOBRID. NEXOBRID ® (anacaulase-bcdb), for topical gel Initial U.S. Approval: 202220250911
1a2f23ad-78ef-43fa-9864-6bd77aac9e57Nexobrid 8.8 % Topical Gel, 55 GMSY10These highlights do not include all the information needed to use NEXOBRID safely and effectively. See full prescribing information for NEXOBRID. NEXOBRID ® (anacaulase-bcdb), for topical gel Initial U.S. Approval: 202220250911